Clinical Trial Update: ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

View source ↗

Summary

This clinical trials registry update reports completion of the ERN-EuroBloodNet registry documenting patients with rare red blood cell defects, including sickle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Hemoglobinopathy
• Sickle Cell Disease

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Hemoglobinopathies, Sickle Cell Disease | Status: COMPLETED